United States · FDA National Drug Code directory

CEO-TWO

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0283-1023_42e0774e-b617-290d-e063-6394a90a199e
Product NDC
0283-1023
Form
SUPPOSITORY
Composition / generic term
Laxative
Labeler
Beutlich Pharmaceuticals, LLC
Marketing category
OTC MONOGRAPH DRUG
Marketing start / end (source format)
20231015
Source listing expiry
20261231

Source-listed ingredients

  • POTASSIUM BITARTRATE — .9 g/5.7g
  • SODIUM BICARBONATE — .6 g/5.7g

These values do not establish equivalence or a dose recommendation.

Packages

  • 2 DOSE PACK in 1 BOX (0283-1023-02) / 5.7 g in 1 DOSE PACK (0283-1023-00) · 0283-1023-02
  • 6 DOSE PACK in 1 BOX (0283-1023-36) / 5.7 g in 1 DOSE PACK (0283-1023-00) · 0283-1023-36
  • 54 DOSE PACK in 1 BOX (0283-1023-54) / 5.7 g in 1 DOSE PACK (0283-1023-00) · 0283-1023-54

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →